Abstract

ObjectiveTo explore the diagnostic value of radiomics model based on magnetic resonance T2-weighted imaging for predicting the recurrence of acute pancreatitis.MethodsWe retrospectively collected 190 patients with acute pancreatitis (AP), including 122 patients with initial acute pancreatitis (IAP) and 68 patients with recurrent acute pancreatitis (RAP). At the same time, the clinical characteristics of the two groups were collected. They were randomly divided into training group and validation group in the ratio of 7:3. One hundred thirty-four cases in the training group, including 86 cases of IAP and 48 cases of RAP. There were 56 cases in the validation group, including 36 cases of IAP and 20 cases of RAP. Least absolute shrinkage and selection operator (LASSO) were used for feature screening. Logistic regression was used to establish the radiomics model, clinical model and combined model for predicting AP recurrence. The predictive ability of the three models was evaluated by the area under the curve (AUC). The recurrence risk in patients with AP was assessed using the nomogram.ResultsThe AUCs of radiomics model in training group and validation group were 0.804 and 0.788, respectively. The AUCs of the combined model in the training group and the validation group were 0.833 and 0.799, respectively. The AUCs of the clinical model in training group and validation group were 0.677 and 0.572, respectively. The sensitivities of the radiomics model, combined model, and clinical model were 0.646, 0.691, and 0.765, respectively. The specificities of the radiomics model, combined model, and clinical model were 0.791, 0.828, and 0.590, respectively. There was no significant difference in AUC between the radiomics model and the combined model for predicting RAP (p = 0.067). The AUCs of the radiomics model and combined model were greater than those of the clinical model (p = 0.008 and p = 0.007, respectively).ConclusionsRadiomics features based on magnetic resonance T2WI could be used as biomarkers to predict the recurrence of AP, and radiomics model and combined model can provide new directions for predicting recurrence of acute pancreatitis.

Highlights

  • Recurrent acute pancreatitis (RAP) is an important global clinical problem [1]

  • Table lists the clinical characteristics of patients in the initial AP patients (IAP) group and RAP group (Table 1)

  • A significant difference in the incidence of hyperlipidemia was noted between the IAP group and RAP group (61/122 vs. 46/68, p < 0.05), but there was no difference in sex, age, severity, complications, gallstones, and alcoholic etiology

Read more

Summary

Introduction

Recurrent acute pancreatitis (RAP) is an important global clinical problem [1]. It is controversial whether RAP is an extension of acute pancreatitis (AP) or an aggravation of chronic disease [2]. In recent years, most studies have shown that AP can be developed into RAP and eventually into chronic pancreatitis (CP) [3, 4]. About 22% of initial AP patients (IAP) develop RAP. Ten percent of IAP patients and 36 percent of relapsing AP patients developed CP [5]. The prevention of the recurrence of acute pancreatitis is the key to preventing the development of acute pancreatitis into chronic pancreatitis [6, 7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call